nach oben

Diabetologia

Erschienen in:

01.09.2009 | Article

Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications

verfasst von: J. Wong, S. V. McLennan, L. Molyneaux, D. Min, S. M. Twigg, D. K. Yue

Erschienen in: Diabetologia | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

We examined whether age of type 2 diabetes onset is related to mitochondrial DNA content in peripheral blood monocytes (PBMCs).

Methods

PBMCs were isolated from 65 patients with type 2 diabetes. To minimise age as a confounder, only patients aged ≥50 years were studied. Sample mitochondrial DNA (mtDNA) content was determined by amplification of the mitochondrial gene CYT-B (also known as MT-CYB) and adjusted for single-copy nuclear control genes (36B4 [also known as RPLPO] and GAPDH).

Results

Age of diabetes onset ranged from 25 to 69 years. There was a significant positive relationship between age of diabetes onset in quartiles and mtDNA content for the whole group (p = 0.02 for trend). When stratified by the presence of diabetes complications, a strong positive relationship was observed between age of diagnosis and mtDNA content for participants without diabetic complications (r = 0.7; p = 0.0002), but not for those with complications (r = −0.04; p = 0.8). Multivariate analysis confirmed age of onset and complication status as independent determinants. There was co-linearity between age of onset and disease duration, with similar relationships also seen between duration and mtDNA content.

Conclusions/interpretation

An earlier age of type 2 diabetes onset is associated with a lower PBMC mtDNA content, but only in patients without diabetes complications. This may reflect a differing biology of PBMC mtDNA in those with early-onset diabetes and those who are prone to complications. PBMC mtDNA depletion may accelerate diabetes onset; however the independent effect of diabetes duration remains to be evaluated.

Yoshiharu T, Toshiharu I, Kana M, Toru E, Azuma K (2008) Predictors of glycemic control in Japanese subjects with type 2 diabetes mellitus. Metab Clin Exp 57:453–457

Hillier TA, Pedula KL (2003) Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 26:2999–3005PubMedCrossRef

Wong J, Molyneaux L, Constantino M, Twigg SM, Yue DK (2008) Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care 31:1985–1990PubMedCrossRef

Ji L, Hou X, Han X (2001) Prevalence and clinical characteristics of mitochondrial tRNA leu(UUR) mt 3243 A→G and ND-1 gene mt 3316 G→A mutations in Chinese patients with type 2 diabetes. Chin Med J (Engl) 114:1205–1207

Wiederkehr A, Wollheim CB (2006) Minireview: implication of mitochondria in insulin secretion and action. Endocrinology 147:2643–2649PubMedCrossRef

Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671PubMedCrossRef

Serradas P, Giroix MH, Saulnier C et al (1995) Mitochondrial deoxyribonucleic acid content is specifically decreased in adult, but not fetal, pancreatic islets of the Goto–Kakizaki rat, a genetic model of noninsulin-dependent diabetes. Endocrinology 136:5623–5631PubMedCrossRef

Antonetti DA, Reynet C, Kahn CR (1995) Increased expression of mitochondrial-encoded genes in skeletal muscle of humans with diabetes mellitus. J Clin Invest 95:1383–1388PubMedCrossRef

Wang H, Hiatt WR, Barstow TJ, Brass EP (1999) Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: alterations with disease. Eur J Appl Physiol Occup Physiol 80:22–27PubMedCrossRef

10.

Sukhorukov VS, Nartsissov RP, Petrichuk SV et al (2000) Comparative diagnostic value of the analysis of the skeletal muscle and lymphocytes in mitochondrial diseases. Arkh Patol 62:19–21PubMed

11.

Lee HK, Song JH, Shin CS et al (1998) Decreased mitochondrial DNA content in peripheral blood precedes the development of non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 42:161–167PubMedCrossRef

12.

Arkan MC, Hevener AL, Greten FR et al (2005) IKK-β links inflammation to obesity-induced insulin resistance. Nat Med 11:191–198PubMedCrossRef

13.

Song J, Oh JY, Sung YA, Pak YK, Park KS, Lee HK (2001) Peripheral blood mitochondrial DNA content is related to insulin sensitivity in offspring of type 2 diabetic patients. Diabetes Care 24:865–869PubMedCrossRef

14.

ML McGill M, Yue DK, Turtle JR (1993) A single visit diabetes complication assessment service: a complement to diabetes management at the primary care level. Diabet Med 10:366–370CrossRef

15.

Group ETDRSR (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98(5 Suppl):786–806

16.

Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553PubMedCrossRef

17.

Gourlain K, Amellal B, Ait Arkoub Z, Dupin N, Katlama C, Calvez V (2003) Quantitative analysis of human mitochondrial DNA using a real-time PCR assay. HIV Med 4:287–292PubMedCrossRef

18.

Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45PubMedCrossRef

19.

Ochi M, Osawa H, Hirota Y et al (2007) Frequency of the G/G genotype of resistin single nucleotide polymorphism at 420 appears to be increased in younger-onset type 2 diabetes. Diabetes 56:2834–2838PubMedCrossRef

20.

Lehman DM, Hunt KJ, Leach RJ et al (2007) Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. Diabetes 56:389–393PubMedCrossRef

21.

Guo Y, Traurig M, Ma L et al (2006) CHRM3 gene variation is associated with decreased acute insulin secretion and increased risk for early-onset type 2 diabetes in Pima Indians. Diabetes 55:3625–3629PubMedCrossRef

22.

Jaakkola U, Pesonen U, Vainio-Jylha E, Koulu M, Pollonen M, Kallio J (2006) The Leu7Pro polymorphism of neuropeptide Y is associated with younger age of onset of type 2 diabetes mellitus and increased risk for nephropathy in subjects with diabetic retinopathy. Exp Clin Endocrinol Diabetes 114:147–152PubMedCrossRef

23.

Flavell DM, Ireland H, Stephens JW et al (2005) Peroxisome proliferator-activated receptor α gene variation influences age of onset and progression of type 2 diabetes. Diabetes 54:582–586PubMedCrossRef

24.

Zeggini E, Parkinson J, Halford S et al (2004) Association studies of insulin receptor substrate 1 gene (irs1) variants in type 2 diabetes samples enriched for family history and early age of onset. Diabetes 53:3319–3322PubMedCrossRef

25.

Oliva R, Novials A, Sánchez M et al (2004) The HFE gene is associated to an earlier age of onset and to the presence of diabetic nephropathy in diabetes mellitus type 2. Endocr 24:111–114CrossRef

26.

Wiltshire S, Frayling TM, Groves CJ et al (2004) Evidence from a large U.K. family collection that genes influencing age of onset of type 2 diabetes map to Chromosome 12p and to the MODY3/NIDDM2 Locus on 12q24. Diabetes 53:855–860PubMedCrossRef

27.

Hanson RL, Bogardus C, Duggan D et al (2007) A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array. Diabetes 56:3045–3052PubMedCrossRef

28.

Curran JE, Johnson MP, Dyer TD et al (2007) Genetic determinants of mitochondrial content. Hum Mol Genet 16:1504–1514PubMedCrossRef

29.

Silva JP, Kohler M, Graff C et al (2000) Impaired insulin secretion and β-cell loss in tissue-specific knockout mice with mitochondrial diabetes. Nat Genet 26:336–340PubMedCrossRef

30.

Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867PubMedCrossRef

31.

Hevener AL, Olefsky JM, Reichart D et al (2007) Macrophage PPAR γ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest 117:1658–1669PubMedCrossRef

32.

Ehses JA, Perren A, Eppler E et al (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356–2370PubMedCrossRef

33.

Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359–407PubMedCrossRef

34.

Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953–964PubMedCrossRef

35.

Heine GH, Ulrich C, Seibert E et al (2007) CD14++CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int 73:622–629PubMedCrossRef

36.

Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625PubMedCrossRef

37.

Yu T, Robotham JL, Yoon Y (2006) Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci U S A 103:2653–2658PubMedCrossRef

38.

Baughman JM, Mootha VK (2006) Buffering mitochondrial DNA variation. Nat Genet 38:1232–1233PubMedCrossRef

39.

Moreno-Loshuertos R, Acin-Perez R, Fernandez-Silva P et al (2006) Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat Genet 38:1261–1268PubMedCrossRef

40.

Nisoli E, Carruba MO (2006) Nitric oxide and mitochondrial biogenesis. J Cell Sci 119:2855–2862PubMedCrossRef

41.

Tedesco L, Valerio A, Cervino C et al (2008) Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes. Diabetes 57:2028–2036PubMedCrossRef

42.

Schick BA, Laaksonen R, Frohlich JJ et al (2007) Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin. Clin Pharmacol Ther 81:650–653PubMedCrossRef

43.

Bogacka I, Xie H, Bray GA, Smith SR (2005) Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 54:1392–1399PubMedCrossRef

44.

Singh R, Hattersley AT, Harries LW (2007) Reduced peripheral blood mitochondrial DNA content is not a risk factor for type 2 diabetes. Diabet Med 24:784–787PubMedCrossRef

Titel: Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications
verfasst von: J. Wong
S. V. McLennan
L. Molyneaux
D. Min
S. M. Twigg
D. K. Yue
Publikationsdatum: 01.09.2009
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 9/2009
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-009-1424-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2009

Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk

Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?